Sort
85,873 grants matching “alzheimers”
Multigenerational Longitudinal Panel for Research on Aging
$2,621,683Steven Ruggles · University Of Minnesota · R01 · FY2024 · AG
Structural and chemical biology
$2,621,195Anirban Banerjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Discovering Small Molecule Activators of Stress-Responsive Signaling
$2,621,070Jeffery W Kelly · Scripps Research Institute, The · RF1 · FY2023 · AG
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$2,619,994Hanzhang Lu · Johns Hopkins University · UF1 · FY2021 · NS
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
$2,618,867Jeffrey Murray Burns · University Of Kansas Medical Center · R33 · FY2021 · AG
Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models
$2,618,631Hollis T Cline · Scripps Research Institute, The · RF1 · FY2022 · AG
Alzheimer's Disease Research Center
$2,617,880John Morris · Washington University · P50 · FY2017 · AG
Alzheimer's Disease Research Center
$2,617,742John Morris · Washington University · P50 · FY2016 · AG
The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimerâs Disease
$2,617,616Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2023 · AG
The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimerâs Disease
$2,617,616Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2024 · AG
Advanced Mass Spectrometry Facility
$2,614,730David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2012 · DK
Age-related changes of cognition in health and disease
$2,614,093Massachusetts General Hospital · P01 · FY2004 · AG
Alzheimer's Disease Research Center
$2,613,980John Morris · Washington University · P50 · FY2019 · AG
Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems.
$2,613,337Amal N. Trivedi · Brown University · P01 · FY2025 · AG
Alzheimer's Disease Research Center
$2,612,940John Morris · Washington University · P50 · FY2018 · AG
Benefits and Harms of Antihypertensive Management Strategies for Nursing Home Residents with ADRD
$2,612,229Daniel Harris · University Of Delaware · RF1 · FY2025 · AG
THERAPEUTIC STRATEGIES FOR ALZHEIMER'S DISEASE BASED ON TREM2 BIOLOGY
$2,611,246Marco Colonna · Washington University · RF1 · FY2019 · AG
APOE as a modifier of prion-like spread in dementia
$2,610,464David R Borchelt · University Of Florida · RF1 · FY2018 · AG
Macrophage Integrated and Targeted Yeast Therapeutics
$2,610,000Christopher Hug · Boston Children'S Hospital · DP2 · FY2011 · OD
Connecting TDP-43 Pathology to the Molecular Profiles of Neurodegeneration
$2,609,330Molly Gale Hammell · Cold Spring Harbor Laboratory · RF1 · FY2020 · NS
Administrative Core
$2,608,910Donovan T Maust · University Of Michigan At Ann Arbor · U54 · FY2025 · AG
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
$2,608,673Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2024 · AG
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
$2,608,006Hui Zheng · Baylor College Of Medicine · P01 · FY2024 · AG
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
$2,608,006Hui Zheng · Baylor College Of Medicine · P01 · FY2022 · AG
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
$2,608,006Hui Zheng · Baylor College Of Medicine · P01 · FY2023 · AG